BM microvessel areas and counts
Subjects (no.) . | Microvessel area as mm2 × 10−2 mean ± 1 SD (median, range) . | Microvessel number in 12.5 mm2 × 10−2 fields mean ± 1 SD (median, range) . | Cellular area as mm2 × 10−2 mean ± 1 SD (median, range) . |
---|---|---|---|
Patients (45) | 0.96 ± 0.83*,† (0.70, 0.45-4.12) | 7.39 ± 7.11* (5, 3-35) | 10.8 ± 1.7 (8.6, 8.7-11.5) |
Controls (12) | 0.09 ± 0.01† (0.09, 0.06-0.12) | 0.66 ± 0.98 (0, 0-3) | 9.7 ± 0.9 (7.8, 6.8-10.7) |
Subjects (no.) . | Microvessel area as mm2 × 10−2 mean ± 1 SD (median, range) . | Microvessel number in 12.5 mm2 × 10−2 fields mean ± 1 SD (median, range) . | Cellular area as mm2 × 10−2 mean ± 1 SD (median, range) . |
---|---|---|---|
Patients (45) | 0.96 ± 0.83*,† (0.70, 0.45-4.12) | 7.39 ± 7.11* (5, 3-35) | 10.8 ± 1.7 (8.6, 8.7-11.5) |
Controls (12) | 0.09 ± 0.01† (0.09, 0.06-0.12) | 0.66 ± 0.98 (0, 0-3) | 9.7 ± 0.9 (7.8, 6.8-10.7) |
P < .001 (analysis of variance by Fisher and Kruskal-Wallis tests followed by paired Duncan [t], Bonferroni [t], and Wilcoxon tests), orP < .0001 (Mann-Whitney test) versus controls.
Microvessel area normalized to the cellular area: patients, 8.9% ± 7.6 (7.4%, 4.1%-35.8%); controls, 0.92% ± 0.1 (0.89%, 0.88%-1.52%).